Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GE Healthcare to acquire Xcellerex
The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines.
The acquisition of Xcellerex will allow GE Healthcare to expand its offering of products and services for the manufacture of biopharmaceuticals such as recombinant proteins, antibodies and vaccines.
Mersana Therapeutics has signed a collaboration agreement with Endo Pharmaceuticals to develop next-generation antibody-drug conjugates (ADCs). Under the deal, Endo will pay an upfront fee to Mersana for
PRM-151 (rhPTX-2) is a recombinant form of human Pentraxin-2, an endogenous human protein that treats fibrosis by regulating the monocyte-derived cells. In a Phase 1 clinical study, PRM-151
The implementation of the Mobile Intelligence provides Rottapharm Madaus Portugal with a simple and fast order-gathering system that utilizes an intuitive graphical user interface (GUI) with features perfectly
Williams replaces Conformetrix’s founder scientists, Andrew Almond, who becomes chief technology officer. Before joining Conformetrix, Williams spent over a decade in the city as a healthcare analyst, with
The company clients will now be able to leverage Almac’s commercial packaging experience and cost-effective commercial packaging solutions. Almac Commercial Operations VP David Downey said addressing the communicated
In the study conducted at Pescara University, 70 perimenopausal women aged 40-50 years were assigned to a placebo or test group, which was given 100mg of Pycnogenol per
Following the acquisition, CareFusion will be able to advance its strategy to offer hospitals safe and efficient systems to manage medication throughout their facilities – from the loading
Topspin Fund, an investment group of James Simons, Leo Guthart and Steve Winick, led the financing, which also includes the participation of existing investors Aisling Capital, OrbiMed Advisors
Jentadueto helps patients to control their blood sugar. It can be taken twice daily and combines two diabetes medicines – the dipeptidyl peptidase-4 (DPP-4) inhibitor, linagliptin and metformin